EndoCleave, An Endonuclease For Viral Vector Manufacturing

EndoCleave is a cutting-edge endonuclease developed by Roche CustomBiotech to address the challenges of viral vector manufacturing. Derived from S.marcescens, this GMP-grade enzyme, produced in our advanced Penzberg, Germany facility, offers superior performance in degrading both DNA and RNA, ensuring the removal of residual and plasmid DNA.

EndoCleave integrates seamlessly into existing biopharmaceutical workflows, boosting efficiency and helping you meet rigorous regulatory standards. With comprehensive supporting documentation included, EndoCleave streamlines your regulatory submissions and ensures compliance.

Trust in Roche's commitment to quality and reliability to elevate your viral vector production. Download the EndoCleave brochure to learn more about how this innovative solution can elevate your viral vector production.